Comment: Abacavir hypersensitivity reaction: An update

Annals of Pharmacotherapy

Volumn 42, Issue 10, 2008, Pages 1519-1520

  Brothers, Cindy H ^a   Hughes, Arlene R ^a   Hernandez, Jaime E ^a   Steel, Helen M ^b   Curtis, Lloyd ^b  

^a GLAXOSMITHKLINE   (United States)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; HLA B ANTIGEN;

ALGORITHM; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DRUG WITHDRAWAL; HUMAN; HYPERSENSITIVITY REACTION; LETTER; PATCH TEST; PRIORITY JOURNAL; PROVOCATION TEST;

ALGORITHMS; ANTI-HIV AGENTS; CLINICAL TRIALS AS TOPIC; DIDEOXYNUCLEOSIDES; DRUG HYPERSENSITIVITY; HLA-B ANTIGENS; HUMANS; PATCH TESTS;

EID: 52949126756     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1K522b     Document Type: Letter

References (4)

1. Hughes CA, Foisy MM, Dewhurst N, et al. Abacavir hypersensitivity reaction: an update. Ann Pharmacother 2008;42:387-96. Epub 26 Beb 2008. DOI 10.1345/aph.1K522
2. Shear NH, Milpied B, Bruynzeel DP, Phillips EJ. A review of drug patch testing and implications for HIV clinicians. AIDS 2008;22:999-1007.
3. Mallal S, Phillips E, Carosi G, et al. HLA-B*5701 screening for hypersensitivity to abacavir. N Engl J Med 2008;358:568-79.
4. Saag M, Balu R, Phillips E, et al. High sensitivity of human leukocyte antigen-b*5701 in immunologically confirmed cases of abacavir hypersensitivity in white and black patients. Clin Infect Dis 2008; 46:1111-8.